|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net (loss) earnings | |||||
| Depreciation and amortization | |||||
| Gain on sale of assets and other | |||||
| Accretion of provisions | |||||
| Decommissioning and restoration costs settled | |||||
| Deferred income tax (recovery) expense | |||||
| Unrealized loss from risk management activities | |||||
| Unrealized foreign exchange loss (gain) | |||||
| Provisions and contract liabilities | |||||
| Asset impairment charges | |||||
| Equity (loss) income, net of distributions from investments | |||||
| Other non-cash items | |||||
| Cash flow from operations before changes in working capital | |||||
| Change in non-cash operating working capital | |||||
| Cash flow from operating activities | |||||
| Investing activities | |||||
| Additions to property, plant and equipment (Note 19 and 37) | |||||
| Additions to intangible assets (Note 21 and 37) | |||||
| Restricted cash (Note 25) | |||||
| Loan advances (Note 23) | |||||
| (Advances) Repayments from loan receivable | |||||
| Increase in long-term financial assets (Note 14) | |||||
| Investments (Note 9) | |||||
| Proceeds on sale of Pioneer Pipeline | |||||
| Proceeds on sale of property, plant and equipment | |||||
| Realized (loss) gain on financial instruments | |||||
| Decrease in finance lease receivable (Note 17) | |||||
| Development expenditures | |||||
| Other | |||||
| Change in non-cash investing working capital balances | |||||
| Cash flow used in investing activities | |||||
| Financing activities | |||||
| Net (decrease) increase in borrowings under credit facilities (Note 25 and 33) | |||||
| Repayment of long-term debt (Note 25 and 33) | |||||
| Issuance of long-term debt (Note 25 and 33) | |||||
| Dividends paid on common shares/preferred shares | |||||
| Common shares | |||||
| Preferred shares | |||||
| Repurchase of common shares under NCIB (Note 28) | |||||
| Proceeds on issuance of common shares | |||||
| Realized gain on financial instruments | |||||
| Acquisition of TransAlta Renewables | |||||
| Distributions paid to subsidiaries' non-controlling interests (Note 12) | |||||
| Decrease in lease liabilities (Note 25 and 33) | |||||
| Financing fees and other | |||||
| Change in non-cash financing working capital balances | |||||
| Cash flow used in financing activities | |||||
| Cash flow used in operating, investing and financing activities | |||||
| Effect of translation on foreign currency cash | |||||
| Decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental cash flow information | |||||
| Cash taxes paid | |||||
| Cash interest paid | |||||
| Cash interest received | |||||
Loading...